Protein kinase D1 (PKD1) phosphorylation promotes dopaminergic neuronal survival during 6-OHDA-induced oxidative stress

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Asaithambi, Arunkumar ^a   Ay, Muhammet ^a   Jin, Huajun ^a   Gosh, Anamitra ^a   Anantharam, Vellareddy ^a   Kanthasamy, Arthi ^a   Kanthasamy, Anumantha G ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; OXIDOPAMINE; PROTEIN KINASE D; PROTEIN KINASE D1; RNA; SERINE; UNCLASSIFIED DRUG; DOPAMINE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MESENCEPHALON; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN FUNCTION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; APOPTOSIS; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

APOPTOSIS; CELL SURVIVAL; DOPAMINE; DOPAMINERGIC NEURONS; HUMANS; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSON DISEASE; PHOSPHORYLATION; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 84900530067     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096947     Document Type: Article

References (67)

1. Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822. (Pubitemid 37339614)
2. Przedborski S (2005) Pathogenesis of nigral cell death in Parkinson's disease. Parkinsonism Relat Disord 11 Suppl 1: S3-7.
3. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909. (Pubitemid 37130207)
4. Malkus KA, Tsika E, Ischiropoulos H (2009) Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle. Mol Neurodegener 4: 24.
5. Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, et al. (2013) Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes. Biochim Biophys Acta. http://dx.doi.org/10. 1016/j.bbadis.2013.09.007.
6. Cassarino DS, Parks JK, Parker WD, Jr., Bennett JP, Jr. (1999) The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta 1453: 49-62. (Pubitemid 29065457)
7. Lotharius J, Dugan LL, O'Malley KL (1999) Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 19: 1284-1293. (Pubitemid 29088911)
8. Latchoumycandane C, Anantharam V, Jin H, Kanthasamy A, Kanthasamy A (2011) Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCdelta in cell culture and animal models of Parkinson's disease. Toxicol Appl Pharmacol 256: 314-323.
9. Stafford MJ, Watson SP, Pears CJ (2003) PKD: a new protein kinase C-dependent pathway in platelets. Blood 101: 1392-1399. (Pubitemid 36182511)
10. Sundram V, Chauhan SC, Jaggi M (2011) Emerging roles of protein kinase D1 in cancer. Mol Cancer Res 9: 985-996.
11. Storz P, Doppler H, Johannes FJ, Toker A (2003) Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation. J Biol Chem 278: 17969-17976. (Pubitemid 36799404)
12. Jaggi M, Du C, Zhang W, Balaji KC (2007) Protein kinase D1: a protein of emerging translational interest. Front Biosci 12: 3757-3767.
13. Rozengurt E (2011) Protein kinase D signaling: multiple biological functions in health and disease. Physiology (Bethesda) 26: 23-33.
14. Van Lint J, Ni Y, Valius M, Merlevede W, Vandenheede JR (1998) Platelet-derived growth factor stimulates protein kinase D through the activation of phospholipase Cgamma and protein kinase C. J Biol Chem 273: 7038-7043. (Pubitemid 28160371)
15. Matthews SA, Liu P, Spitaler M, Olson EN, McKinsey TA, et al. (2006) Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes. Mol Cell Biol 26: 1569-1577. (Pubitemid 43202580)
16. Jamora C, Yamanouye N, Van Lint J, Laudenslager J, Vandenheede JR, et al. (1999) Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell 98: 59-68.
17. Haussermann S, Kittstein W, Rincke G, Johannes FJ, Marks F, et al. (1999) Proteolytic cleavage of protein kinase Cmu upon induction of apoptosis in U937 cells. FEBS Lett 462: 442-446.
18. Prigozhina NL, Waterman-Storer CM (2004) Protein kinase D-mediated anterograde membrane trafficking is required for fibroblast motility. Curr Biol 14: 88-98. (Pubitemid 38203920)
19. Zhukova E, Sinnett-Smith J, Rozengurt E (2001) Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells. J Biol Chem 276: 40298-40305.
20. Storz P, Doppler H, Toker A (2005) Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Mol Cell Biol 25: 8520-8530. (Pubitemid 41369173)
21. Sidorenko SP, Law CL, Klaus SJ, Chandran KA, Takata M, et al. (1996) Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling. Immunity 5: 353-363. (Pubitemid 26366758)
22. Anantharam V, Kitazawa M, Wagner J, Kaul S, Kanthasamy AG (2002) Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J Neurosci 22: 1738-1751. (Pubitemid 35386292)
23. Prasad KN, Clarkson ED, La Rosa FG, Edwards-Prasad J, Freed CR (1998) Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism: a review. Mol Genet Metab 65: 1-9. (Pubitemid 28509602)
24. Kanthasamy K, Gordon R, Jin H, Anantharam V, Ali S, et al. (2011) Neuroprotective effect of resveratrol against methamphetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity. Curr Neuropharmacol 9: 49-53.
25. Lin M, Chandramani-Shivalingappa P, Jin H, Ghosh A, Anantharam V, et al. (2012) Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells. Neuroscience 210: 308-332.
26. Peng J, Mao XO, Stevenson FF, Hsu M, Andersen JK (2004) The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J Biol Chem 279: 32626-32632. (Pubitemid 39014720)
27. Lopert P, Day BJ, Patel M (2012) Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells. PLoS One 7: e50683.
28. Ortiz-Ortiz MA, Moran JM, Bravosanpedro JM, Gonzalez-Polo RA, Niso-Santano M, et al. (2009) Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species. Neurotoxicology 30: 1008-1018.
29. Chandramani Shivalingappa P, Jin H, Anantharam V, Kanthasamy A, Kanthasamy A (2012) N-Acetyl Cysteine Protects against Methamphetamine-Induced Dopaminergic Neurodegeneration via Modulation of Redox Status and Autophagy in Dopaminergic Cells. Parkinsons Dis 2012: 424285.
30. Kanthasamy AG, Anantharam V, Zhang D, Latchoumycandane C, Jin H, et al. (2006) A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models. Free Radic Biol Med 41: 1578-1589. (Pubitemid 44528253)
31. Zhang D, Kanthasamy A, Yang Y, Anantharam V (2007) Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J Neurosci 27: 5349-5362. (Pubitemid 46790158)
32. Ghosh A, Saminathan H, Kanthasamy A, Anantharam V, Jin H, et al. (2013) The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease. J Biol Chem 288: 21955-21971.
33. Dranka BP, Zielonka J, Kanthasamy AG, Kalyanaraman B (2012) Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation. J Neurochem 122: 941-951.
34. Hanrott K, Gudmunsen L, O'Neill MJ, Wonnacott S (2006) 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem 281: 5373-5382. (Pubitemid 43847631)
35. Xu Q, Kanthasamy AG, Reddy MB (2011) Phytic Acid Protects against 6-Hydroxydopamine-Induced Dopaminergic Neuron Apoptosis in Normal and Iron Excess Conditions in a Cell Culture Model. Parkinsons Dis 2011: 431068.
36. Friling S, Bergsland M, Kjellander S (2009) Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease. BMC Neurosci 10: 146.
37. Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, et al. (2011) LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8: 267-280.
38. Jin H, Kanthasamy A, Anantharam V, Rana A, Kanthasamy AG (2011) Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death. J Biol Chem 286: 19840-19859.
39. Jin H, Kanthasamy A, Ghosh A, Yang Y, Anantharam V, et al. (2011) alpha-Synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J Neurosci 31: 2035-2051.
40. Martin DP, Anantharam V, Jin H, Witte T, Houk R, et al. (2011) Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease. Neurotoxicology 32: 554-562.
41. Harischandra DS, Kondru N, Martin D, Kanthasamy A, Jin H, et al. (2014) Role of proteolytic activation of protein kinase Cdelta in the pathogenesis of prion disease. Prion 8: 142-152.
42. Storz P, Toker A (2003) Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. Embo J 22: 109-120. (Pubitemid 36091274)
43. Yang Y, Kaul S, Zhang D, Anantharam V, Kanthasamy AG (2004) Suppression of Caspase-3-dependent proteolytic activation of protein kinase C-delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration. Molecular and Cellular Neuroscience 25: 406-421. (Pubitemid 38366406)
44. Storz P, Doppler H, Toker A (2004) Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling. Mol Cell Biol 24: 2614-2626. (Pubitemid 38381256)
45. Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, et al. (2005) Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. J Biol Chem 280: 28721-28730. (Pubitemid 41105773)
46. Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10 Suppl: S18-25.
47. Przedborski S, Vila M (2003) The 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Ann N Y Acad Sci 991: 189-198. (Pubitemid 36793814)
48. Subramaniam S, Unsicker K (2010) ERK and cell death: ERK1/2 in neuronal death. FEBS J 277: 22-29.
49. Philpott KL, Facci L (2008) MAP kinase pathways in neuronal cell death. CNS Neurol Disord Drug Targets 7: 83-97. (Pubitemid 351516219)
50. Chong ZZ, Li F, Maiese K (2005) Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75: 207-246. (Pubitemid 40693131)
51. Zhang L, Qu Y, Tang J, Chen D, Fu X, et al. (2010) PI3K/Akt signaling pathway is required for neuroprotection of thalidomide on hypoxic-ischemic cortical neurons in vitro. Brain Res 1357: 157-165.
52. Storz P (2007) Mitochondrial ROS-radical detoxification, mediated by protein kinase D. Trends Cell Biol 17: 13-18.
53. Song J, Li J, Qiao J, Jain S, Mark Evers B, et al. (2009) PKD prevents H2O2-induced apoptosis via NF-kappaB and p38 MAPK in RIE-1 cells. Biochem Biophys Res Commun 378: 610-614.
54. Storz P, Doppler H, Toker A (2004) Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB. Mol Pharmacol 66: 870-879. (Pubitemid 39319459)
55. Yuan J, Bae D, Cantrell D, Nel AE, Rozengurt E (2002) Protein kinase D is a downstream target of protein kinase Ctheta. Biochem Biophys Res Commun 291: 444-452. (Pubitemid 34687366)
56. Waldron RT, Rozengurt E (2003) Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J Biol Chem 278: 154-163. (Pubitemid 36043557)
57. Brandlin I, Hubner S, Eiseler T, Martinez-Moya M, Horschinek A, et al. (2002) Protein kinase C (PKC)eta-mediated PKC mu activation modulates ERK and JNK signal pathways. J Biol Chem 277: 6490-6496. (Pubitemid 34968446)
58. Tan M, Xu X, Ohba M, Ogawa W, Cui MZ (2003) Thrombin rapidly induces protein kinase D phosphorylation, and protein kinase C delta mediates the activation. J Biol Chem 278: 2824-2828. (Pubitemid 36801185)
59. Gomez-Lazaro M, Bonekamp NA, Galindo MF, Jordan J, Schrader M (2008) 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells. Free Radic Biol Med 44: 1960-1969.
60. Elkon H, Melamed E, Offen D (2001) 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease. Cell Mol Neurobiol 21: 771-781. (Pubitemid 34538869)
61. Matthews SA, Rozengurt E, Cantrell D (1999) Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/Protein kinase Cmu. J Biol Chem 274: 26543-26549.
62. Rybin VO, Guo J, Steinberg SF (2009) Protein kinase D1 autophosphorylation via distinct mechanisms at Ser744/Ser748 and Ser916. J Biol Chem 284: 2332-2343.
63. Celil AB, Campbell PG (2005) BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280: 31353-31359. (Pubitemid 41291875)
64. Asaithambi A, Kanthasamy A, Saminathan H, Anantharam V, Kanthasamy AG (2011) Protein kinase D1 (PKD1) activation mediates a compensatory protective response during early stages of oxidative stress-induced neuronal degeneration. Mol Neurodegener 6: 43.
65. Parra M, Kasler H, McKinsey TA, Olson EN, Verdin E (2005) Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J Biol Chem 280: 13762-13770. (Pubitemid 40517272)
66. Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, et al. (2004) Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 24: 8374-8385. (Pubitemid 39245060)
67. Rey O, Sinnett-Smith J, Zhukova E, Rozengurt E (2001) Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation. J Biol Chem 276: 49228-49235.